8-18061724-G-T

Variant summary

Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5

The NM_177924.5(ASAH1):​c.665C>A​(p.Thr222Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T222I) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

ASAH1
NM_177924.5 missense

Scores

11
6
1

Clinical Significance

Pathogenic no assertion criteria provided P:1

Conservation

PhyloP100: 8.45

Publications

8 publications found
Variant links:
Genes affected
ASAH1 (HGNC:735): (N-acylsphingosine amidohydrolase 1) This gene encodes a member of the acid ceramidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. Processing of this preproprotein generates alpha and beta subunits that heterodimerize to form the mature lysosomal enzyme, which catalyzes the degradation of ceramide into sphingosine and free fatty acid. This enzyme is overexpressed in multiple human cancers and may play a role in cancer progression. Mutations in this gene are associated with the lysosomal storage disorder, Farber lipogranulomatosis, and a neuromuscular disorder, spinal muscular atrophy with progressive myoclonic epilepsy. [provided by RefSeq, Oct 2015]
ASAH1 Gene-Disease associations (from GenCC):
  • ASAH1-related sphingolipidosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Farber lipogranulomatosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • spinal muscular atrophy-progressive myoclonic epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.969
PP5
Variant 8-18061724-G-T is Pathogenic according to our data. Variant chr8-18061724-G-T is described in ClinVar as Pathogenic. ClinVar VariationId is 91.Status of the report is no_assertion_criteria_provided, 0 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_177924.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASAH1
NM_177924.5
MANE Select
c.665C>Ap.Thr222Lys
missense
Exon 9 of 14NP_808592.2
ASAH1
NM_004315.6
c.713C>Ap.Thr238Lys
missense
Exon 9 of 14NP_004306.3
ASAH1
NM_001127505.3
c.647C>Ap.Thr216Lys
missense
Exon 9 of 14NP_001120977.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASAH1
ENST00000637790.2
TSL:1 MANE Select
c.665C>Ap.Thr222Lys
missense
Exon 9 of 14ENSP00000490272.1
ASAH1
ENST00000381733.9
TSL:1
c.713C>Ap.Thr238Lys
missense
Exon 9 of 14ENSP00000371152.4
ASAH1
ENST00000314146.10
TSL:1
c.647C>Ap.Thr216Lys
missense
Exon 9 of 14ENSP00000326970.10

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1427166
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
706674
African (AFR)
AF:
0.00
AC:
0
AN:
32496
American (AMR)
AF:
0.00
AC:
0
AN:
40538
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25556
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37954
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81776
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51316
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5722
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1092730
Other (OTH)
AF:
0.00
AC:
0
AN:
59078
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Farber lipogranulomatosis Pathogenic:1
Dec 20, 1996
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Pathogenic
0.44
D
BayesDel_noAF
Pathogenic
0.39
CADD
Pathogenic
29
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.94
D
Eigen
Pathogenic
0.78
Eigen_PC
Pathogenic
0.67
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.94
D
M_CAP
Uncertain
0.14
D
MetaRNN
Pathogenic
0.97
D
MetaSVM
Uncertain
0.70
D
MutationAssessor
Pathogenic
3.1
M
PhyloP100
8.4
PrimateAI
Uncertain
0.54
T
PROVEAN
Pathogenic
-4.7
D
REVEL
Pathogenic
0.82
Sift
Uncertain
0.0020
D
Sift4G
Benign
0.065
T
Polyphen
0.99
D
Vest4
0.94
MutPred
0.91
Gain of ubiquitination at T222 (P = 0.0258)
MVP
0.96
MPC
0.0078
ClinPred
0.99
D
GERP RS
5.6
Varity_R
0.92
gMVP
0.98
Mutation Taster
=1/99
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137853593; hg19: chr8-17919233; API